Literature DB >> 2996694

Calcitonin receptors in the rat mesencephalon mediate its analgesic actions: autoradiographic and behavioral analyses.

A Fabbri, F Fraioli, C B Pert, A Pert.   

Abstract

Autoradiographic analyses of salmon calcitonin (sCT) binding in the rat mesencephalon revealed an exceptionally high concentration of receptors in the ventral and ventrolateral segments of the periaqueductal gray matter (PAG) extending along the entire rostral-caudal axis. Relatively heavy labeling was also seen along a band extending ventrolaterally through the mesencephalic reticular formation. Other receptor-rich areas include the nucleus linearis, pars compacta and lateralis of the substantia nigra, locus coeruleus, parabrachial nuclei and nucleus raphe pontis of the pontine reticular formation. Injections of sCT into the PAG induced a dose-dependent increase in hot-plate latencies. All rostral-caudal levels of these brain regions appeared to be equally responsive. Injections into the midline pontine reticular formation were also effective in increasing response latencies. Unilateral injections into the hypothalamus, medial thalamus, ventral thalamus and mesencephalic reticular formation proved to be ineffective. Human calcitonin (hCT) was considerably less potent. These biological effects are consistent with the potencies of both peptides in displacing 125I-sCT from slide-mounted sections of rat PAG. Naloxone failed to antagonize sCT-induced analgesia, suggesting an opiate independent mechanism for this peptide in eliciting analgesia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2996694     DOI: 10.1016/0006-8993(85)90736-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

Review 1.  Central nervous system binding sites for calcitonin and calcitonin gene-related peptide.

Authors:  P M Sexton
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

2.  Effects of calcitonin on human auditory and visual evoked brain potentials.

Authors:  R Pietrowsky; M Dentler; H L Fehm; J Born
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  The effectiveness of calcitonin on chronic back pain and daily activities in postmenopausal women with osteoporosis.

Authors:  G Papadokostakis; J Damilakis; E Mantzouranis; P Katonis; A Hadjipavlou
Journal:  Eur Spine J       Date:  2005-09-29       Impact factor: 3.134

4.  Reversible calcitonin binding to solubilized sheep brain binding sites.

Authors:  P M Sexton; H G Schneider; C S D'Santos; F A Mendelsohn; B E Kemp; J M Moseley; T J Martin; D M Findlay
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

Review 5.  Managing acute osteoporotic vertebral fractures with calcitonin.

Authors:  W P Maksymowych
Journal:  Can Fam Physician       Date:  1998-10       Impact factor: 3.275

Review 6.  Calcitonin and its antinociceptive activity: animal and human investigations 1975-1992.

Authors:  P C Braga
Journal:  Agents Actions       Date:  1994-05

7.  In vitro study of the interaction of salmon calcitonin with mu, delta and kappa opioid agonists.

Authors:  M I Martín; M J Alfaro; C Goicoechea; M I Colado
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

8.  Microinjection of calcitonin in midbrain periaqueductal gray attenuates hyperalgesia in a chronic constriction injury rat model.

Authors:  Zongpeng Li; Zong Gao; Shufa Li; Yuanyuan Zhang; Lizhi Xing; Lanju Zhang; Guijie Ma; Xinbo Zhao; Mingtao Shao
Journal:  Iran J Basic Med Sci       Date:  2015-01       Impact factor: 2.699

9.  An immunohistochemical study of the antinociceptive effect of calcitonin in ovariectomized rats.

Authors:  Bunji Takayama; Shin-ichi Kikuchi; Shin-ichi Konno; Miho Sekiguchi
Journal:  BMC Musculoskelet Disord       Date:  2008-12-15       Impact factor: 2.362

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.